Ameriprise’s Jade Biosciences JBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.14M Sell
81,122
-25,931
-24% -$520K ﹤0.01% 3391
2026
Q2
$2.38M Buy
+107,053
New +$2.23M ﹤0.01% 2987
2026
Q1
– Sell
-187,254
Closed -$2.89M – 4062
2025
Q4
$2.89M Buy
+187,254
New +$2.2M ﹤0.01% 2801

Other funds holding JBIO

Ameriprise's JBIO Position: Q3 2026 in Review

Ameriprise reduced its Jade Biosciences (JBIO) stake by 24% in Q3 2026, selling an estimated $520K and leaving 81,122 shares worth $1.14M. The position accounts for ﹤0.01% of the portfolio, ranked #3391.

Ameriprise first reported a position in JBIO in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.89M in Q4 2025. 162 funds tracked by Wall St. Rank hold JBIO as of Q3 2026.

  • Ameriprise held 81,122 shares of Jade Biosciences worth $1.14M as of Q3 2026.
  • Ameriprise sold 25,931 Jade Biosciences shares in Q3 2026, an estimated $520K.
  • Jade Biosciences made up ﹤0.01% of Ameriprise's portfolio in Q3 2026, its #3391 holding.
  • Ameriprise first reported a position in Jade Biosciences in Q4 2025 and has held it in 3 quarters since.
  • Ameriprise's Jade Biosciences position peaked at $2.89M in Q4 2025.
  • 162 funds tracked by Wall St. Rank held Jade Biosciences as of Q3 2026.

Based on Ameriprise's 13F filing for Q3 2026, filed 16 Nov 2026.